ArticleScientific data2025
A Multi-phase CT Dataset for Automated Differential Diagnosis of Liver Tumors.
Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative multiphase CT radiomics for differentiating isolated hepatic metastasis from intrahepatic cholangiocarcinoma: a two-center study of native, subtraction, peritumoral, and fusion models.Frontiers in oncology · 2026Article
- Explainable machine learning-based multiphase contrast-enhanced CT radiomics for noninvasively predicting GPC3 expression in hepatocellular carcinoma: a bicentric study.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver tumors exhibit significant heterogeneity in etiology, pathology, and treatment response, making accurate differential diagnosis critical for diagnosis and management. While multi-phase contrast-enhanced computed tomography (CT) provides valuable imaging patterns for differentiation, visual assessment alone is often limited by overlapping features. To address this, we present MCT-LTDiag, a comprehensive Multi-phase CT dataset for Liver Tumor Diagnosis, comprising 517 cases with four-phase contrast-enhanced CT scans (non-contrast, arterial, portal venous, and delayed phases) and five tumor subtypes: hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), colorectal liver metastasis (CRLM), breast cancer liver metastasis (BCLM), and hepatic hemangioma (HH). The dataset features standardized preprocessing, rigorous quality control, and expert-annotated tumor masks. Baseline experiments using radiomics-based machine learning and deep learning models demonstrate the dataset's utility, with multi-phase integration significantly improving diagnostic performance. MCT-LTDiag serves as a benchmark for advancing automated liver tumor subtype classification and is publicly available to support future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.